Bioprocess containers are single-use flexible container systems that are utilized in the upstream and downstream processes for sterile liquid-handling applications in the biopharmaceutical industry. These containers are employed in the preparation of cell media and are a cost-effective alternative to conventional stainless-steel systems. Growth in the bioprocess containers market is mainly driven by factors such as the increasing demand for biologics, affordability, and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination.
The booming biopharma industry in emerging countries is also expected to offer a wide range of growth opportunities to players in the market. On the other hand, issues related to leachable and extractable and increasing market consolidation are expected to challenge market growth to a certain extent during the forecast period.
For More Information Download PDF Brochure @
The biopharmaceutical companies segment is expected to dominate the market during the forecast period, while the life science R&D companies segment is expected to grow at the highest CAGR. Biopharmaceutical manufacturing is generally characterized using single-use technologies including bioprocess containers. Bioprocess container systems, due to their cost-effectiveness, have found wide use in biopharmaceutical manufacturing as they can lower the overall cost of production.
A major factor driving the biologics market is the rapidly increasing global geriatric population. According to the US Census Bureau, in 2015, an estimated 8.5% (or 617.1 million individuals) of the global population was aged 65 years and older; by 2030, this figure is estimated to reach 22%. In the same year, the aging population accounted for 18.6% of the total population in the US and 18.9% of the total population in Europe.
bioprocess containersThermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).